Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study

MLA

Hauke Basedau, et al. “Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Erenumab-Specific Central Effects: An FMRI Study.” The Journal of Headache and Pain, vol. 25, no. 1, Jan. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s10194-023-01709-8.

APA

Hauke Basedau, Kuan-Po Peng, Marlene Schellong, & Arne May. (2024). Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study. The Journal of Headache and Pain, 25(1), 1–9. https://doi.org/10.1186/s10194-023-01709-8

Chicago

Hauke Basedau, Kuan-Po Peng, Marlene Schellong, and Arne May. 2024. “Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Erenumab-Specific Central Effects: An FMRI Study.” The Journal of Headache and Pain 25 (1): 1–9. doi:10.1186/s10194-023-01709-8.